Angion
Angion is committed to transforming the treatment paradigm for patients suffering from fibrotic diseases.
19 employees · est. 1998 · United States
Cara Therapeutics
Transforming the way pruritus is treated to bring quality to the lives of those who suffer
46 employees · est. 2004 · Stamford, United States
Angion is the older company (1998 vs 2004).
Side-by-Side Comparison
| Metric | Angion | Cara Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 1998 older | 2004 |
| Headquarters | ||
| Headquarters | United States | Stamford, United States |
| Employees | ||
| Employees | 19 | 46 |
| Industry | ||
| Industry | Biopharma, Biotechnology | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Post Ipo Debt |
| Total Funding | ||
| Total Funding | $84.27M | $517.20M |
| Funding Rounds | ||
| Funding Rounds | 7 | 10 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical Company, Drug Discovery, Organ Restoration, Renal Disease, Fibrotic Diseases, Acute Organ Injuries, Small Molecule Therapeutics, Clinical-stage, Delayed Graft Function, Acute Kidney Injury, Cardiopulmonary Bypass, Phase 3, Phase 2, Late-stage, Patient Treatment Paradigm | Biopharmaceutical Company, Pruritus Treatment, KORSUVA, Difelikefalin, FDA-approved Treatment, Chronic Kidney Disease, Hemodialysis, Oral Formulation, Phase 3 Programs, Non-dialysis Dependent Advanced Chronic Kidney Disease, Atopic Dermatitis, Notalgia Paresthetica, Clinical Trials, Innovation, Medical Research |
| Website | ||
| Website | angion.com | caratherapeutics.com |
About Angion
Angion is a late-stage biopharmaceutical company committed to transforming the treatment paradigm for patients suffering from fibrotic diseases. Established in 1998 and headquartered in the United States, Angion focuses on the discovery, development, and commercialization of novel small molecule the...
About Cara Therapeutics
Cara Therapeutics, founded in 2004 and headquartered in the United States, is a biopharmaceutical innovator committed to enhancing the treatment of pruritus through novel therapeutic approaches. With its slogan, "Transforming the way pruritus is treated to bring quality to the lives of those who suf...
We will tell you when either one moves
BounceWatch watches Angion and Cara Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Angion and Cara Therapeutics — by email.
Frequently Asked Questions
Compare Angion with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Angion on 12 Sep 2024, and Cara Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.